Amicus Therapeutics, Inc. (FOLD)
14.38
+0.06
(+0.42%)
USD |
NASDAQ |
Jan 14, 16:00
14.39
+0.01
(+0.07%)
Pre-Market: 09:18
Amicus Therapeutics SG&A Expense (TTM): 353.07M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 973.41M |
| CorMedix, Inc. | 75.56M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Ekso Bionics Holdings, Inc. | 15.70M |
| Gilead Sciences, Inc. | 5.886B |